Table 3. Univariate and multivariate survival analyses in 88 patients with lymph node-positive cervical cancer.
Disease-free survival
|
Overall survival
|
|||||
---|---|---|---|---|---|---|
Univariate a |
Multivariate
b
|
Univariate a |
Multivariate
b
|
|||
P-value | P-value | HR (95% CI) | P-value | P-value | HR (95% CI) | |
Lymph node-density (⩽10% vs >10%) | 0.01 | 0.03 | 2.2 (1.1–4.7) | 0.01 | 0.046 | 2.2 (1.0–4.8) |
FIGO stage (I vs II vs III vs IV) | 0.01 | 0.002 | 2.0 (1.3–3.2) | 0.008 | 0.002 | 2.1 (1.3–3.4) |
Patients' age | 0.5 | 0.07 | 1.0 (0.9–1.1) | 0.8 | 0.09 | 0.9 (0.9–1.0) |
Histological grade (G1 vs G2 vs G3) | 0.03 | 0.09 | 1.6 (0.9–2.7) | 0.05 | 0.07 | 1.7 (0.9–2.9) |
Histological type (squamous cell carcinoma vs adenosquamous carcinoma) | 0.01 | 0.03 | 2.2 (1.1–4.7) | 0.2 | 0.08 | 2.0 (0.9–4.4) |
Abbreviations: 95% CI=95% confidence interval; FIGO=International Federation of Gynecologists and Obstetricians; HR=hazard ratio.
Log-rank test.
Multivariate Cox-regression analysis.